ATE230389T1 - Angiogenese inhibitoren - Google Patents

Angiogenese inhibitoren

Info

Publication number
ATE230389T1
ATE230389T1 AT99102501T AT99102501T ATE230389T1 AT E230389 T1 ATE230389 T1 AT E230389T1 AT 99102501 T AT99102501 T AT 99102501T AT 99102501 T AT99102501 T AT 99102501T AT E230389 T1 ATE230389 T1 AT E230389T1
Authority
AT
Austria
Prior art keywords
angiogenesis inhibitors
angiogenesis
inhibitors
Prior art date
Application number
AT99102501T
Other languages
English (en)
Inventor
Chiho Fukiage
Mitsuyoshi Azuma
Jun Rui Inoue
Masayuki Nakamura
Yuka Yoshida
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE230389T1 publication Critical patent/ATE230389T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99102501T 1995-10-25 1996-10-23 Angiogenese inhibitoren ATE230389T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27748595 1995-10-25
JP24804696 1996-09-19

Publications (1)

Publication Number Publication Date
ATE230389T1 true ATE230389T1 (de) 2003-01-15

Family

ID=26538555

Family Applications (3)

Application Number Title Priority Date Filing Date
AT99106760T ATE239698T1 (de) 1995-10-25 1996-10-23 Angiogenese hemmer
AT96116994T ATE230275T1 (de) 1995-10-25 1996-10-23 Angiogense-inhibitor
AT99102501T ATE230389T1 (de) 1995-10-25 1996-10-23 Angiogenese inhibitoren

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT99106760T ATE239698T1 (de) 1995-10-25 1996-10-23 Angiogenese hemmer
AT96116994T ATE230275T1 (de) 1995-10-25 1996-10-23 Angiogense-inhibitor

Country Status (13)

Country Link
US (2) US6057290A (de)
EP (2) EP0771565B1 (de)
AR (1) AR004694A1 (de)
AT (3) ATE239698T1 (de)
AU (1) AU716495B2 (de)
BR (1) BR9605267A (de)
CA (1) CA2188817C (de)
DE (3) DE69625622T2 (de)
ES (2) ES2190139T3 (de)
HU (1) HUP9602943A3 (de)
MX (1) MX9605156A (de)
NO (1) NO964514L (de)
PL (1) PL316669A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2226740A1 (en) * 1995-07-13 1997-01-30 Mitsuyoshi Azuma Piperazine derivative and its uses
US6214800B1 (en) * 1995-10-25 2001-04-10 Senju Pharmaceutical Co., Ltd. Angiogenesis inhibitor
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
ES2201524T3 (es) * 1997-09-04 2004-03-16 Nippon Chemiphar Co., Ltd. Derivados de epoxisuccinamida.
US6015787A (en) * 1997-11-04 2000-01-18 New England Medical Center Hospitals, Inc. Cell-permeable protein inhibitors of calpain
DE69939075D1 (de) 1998-03-05 2008-08-21 Senju Pharma Co Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
KR20010041967A (ko) * 1998-03-20 2001-05-25 요시다 쇼지 뇌조직 장애를 예방 및 치료하기 위한 시스테인프로테아제 억제제 함유 약제학적 조성물
GB9819860D0 (en) * 1998-09-12 1998-11-04 Zeneca Ltd Chemical compounds
EP1140194A2 (de) 1998-12-23 2001-10-10 G.D. SEARLE & CO. Verwendung von einen cyclooxygenase-2 inhibitor, einen matrix metalloproteinase-inhibitor, einen antineoplastische wirkstoff und wahlweise bestrahlung als kombinationsterapie von neoplasie
AU3196300A (en) * 1999-03-26 2000-10-16 Shionogi & Co., Ltd. Carbocyclic sulfonamide derivatives
KR20010001270A (ko) 1999-06-03 2001-01-05 복성해 혈관신생을 억제하는 새로운 이소쿠마린 유도체
US7052714B1 (en) 1999-10-13 2006-05-30 Senju Pharmaceutical Co., Ltd Ophthalmic adhesive preparations for percutaneous adsorption
AU1735001A (en) * 1999-12-10 2001-06-18 Senju Pharmaceutical Co., Ltd. Cyclodextrin-containing pharmaceutical composition
JPWO2002034252A1 (ja) * 2000-10-26 2004-03-04 千寿製薬株式会社 ジペプチジルアルデヒド誘導体含有医薬組成物
AU2002221066A1 (en) * 2000-12-12 2002-06-24 Senju Pharmaceutical Co. Ltd. Hydrazone derivatives and use thereof in medicines
CZ20033296A3 (cs) * 2001-06-06 2004-04-14 Eli Lilly And Company Benzoylsulfonamidy a sulfonylbenzamidiny jako protinádorové sloučeniny
US7115607B2 (en) * 2001-07-25 2006-10-03 Amgen Inc. Substituted piperazinyl amides and methods of use
WO2003078415A1 (fr) * 2002-03-15 2003-09-25 Senju Pharmaceutical Co., Ltd. Derive de l'hemiacetal cyclique et son utilisation
AU2003236180A1 (en) 2002-03-29 2003-10-13 Senju Pharmaceutical Co., Ltd. Hydroxymorpholinone derivative and medicinal use thereof
EP1354586A1 (de) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH Verwendung von Hydroxypyridon Derivaten zur Wundheilung
ES2332363T3 (es) * 2002-07-22 2010-02-03 Senju Pharmaceutical Co., Ltd. Nuevos derivados de alfa-cetoamida y su uso.
GB0314262D0 (en) 2003-06-19 2003-07-23 Univ Nottingham Trent Novel compounds and methods of using the same
US7615556B2 (en) * 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
US8236798B2 (en) 2009-05-07 2012-08-07 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
EP2541716A1 (de) 2010-02-25 2013-01-02 Panasonic Corporation Bedarfs- und ausgabesteuerungsvorrichtung, bedarfs- und ausgabesteuerungsverfahren sowie programm dafür
CN103052382B (zh) 2010-07-14 2014-10-22 千寿制药株式会社 α-酮酰胺衍生物的固体分散体
GB201218084D0 (en) * 2012-10-09 2012-11-21 Univ Aston Novel compounds and methods for use in medicine
GB201220474D0 (en) * 2012-11-14 2012-12-26 Sagetis Biotech Sl Polypeptides
WO2019217410A1 (en) * 2018-05-07 2019-11-14 Neuro Theranostics, Inc. Compositions and methods for treating traumatic brain injury
WO2022187491A1 (en) * 2021-03-03 2022-09-09 The Texas A& M University System Inhibitors of cysteine proteases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50137951A (de) 1974-04-27 1975-11-01
JPS5754157A (en) 1980-09-19 1982-03-31 Nippon Kayaku Co Ltd L-argininal derivative and its preparation
PT84170B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas
JP2536754B2 (ja) * 1987-05-08 1996-09-18 日本ケミファ株式会社 ピペラジン誘導体
JPH0832698B2 (ja) * 1987-05-08 1996-03-29 日本ケミファ株式会社 ピペラジン誘導体
US5510531A (en) 1989-04-10 1996-04-23 Suntory Limited Proteinase inhibitor
JP2701932B2 (ja) * 1989-04-10 1998-01-21 サントリー株式会社 タンパク質分解酵素阻害剤
DE69024400T2 (de) * 1989-04-28 1996-06-27 Takara Shuzo Co Dem menschlichen Calpastatin ähnliches Polypeptid
WO1992014696A2 (en) 1991-02-22 1992-09-03 The Du Pont Merck Pharmaceutical Company SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES
EP0504938A3 (en) * 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
CA2071621C (en) * 1991-06-19 1996-08-06 Ahihiko Hosoda Aldehyde derivatives
JP2848232B2 (ja) 1993-02-19 1999-01-20 武田薬品工業株式会社 アルデヒド誘導体
US5607831A (en) 1993-03-25 1997-03-04 The United States Of America As Represented By The Department Of Health And Human Services In vitro methods for assessing the susceptibility of HIV-1-infected individuals to cysteine protease-mediated activation-induced programmed cell death
US5658885A (en) 1993-04-27 1997-08-19 The Dupont Merck Pharmaceutical Company Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
JP3599287B2 (ja) * 1993-04-28 2004-12-08 三菱化学株式会社 スルホンアミド誘導体
CA2196182A1 (en) * 1994-09-27 1996-04-04 Takashi Sohda Aldehyde derivatives as upsteine protease inhibitors
US5614649A (en) 1994-11-14 1997-03-25 Cephalon, Inc. Multicatalytic protease inhibitors
EP0731107A1 (de) * 1995-02-13 1996-09-11 Takeda Chemical Industries, Ltd. Herstellung von Aldehyd-Derivaten
AU706064B2 (en) 1995-05-10 1999-06-10 Darwin Discovery Limited Peptide compounds which inhibit metalloproteinase and TNF liberation, and their therapeutic use
CA2226740A1 (en) * 1995-07-13 1997-01-30 Mitsuyoshi Azuma Piperazine derivative and its uses
EP0910564B1 (de) 1995-11-28 2007-10-31 Cephalon, Inc. Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer

Also Published As

Publication number Publication date
ATE230275T1 (de) 2003-01-15
HUP9602943A3 (en) 1998-03-02
HUP9602943A2 (en) 1997-08-28
DE69625622D1 (de) 2003-02-06
AR004694A1 (es) 1999-03-10
CA2188817C (en) 2010-01-26
CA2188817A1 (en) 1997-04-26
US6057290A (en) 2000-05-02
AU7038496A (en) 1997-05-01
EP0771565A3 (de) 1998-11-04
ES2193615T3 (es) 2003-11-01
AU716495B2 (en) 2000-02-24
EP0771565B1 (de) 2003-01-02
DE69625575T2 (de) 2003-09-25
EP0927716B1 (de) 2003-05-07
BR9605267A (pt) 1998-07-21
EP0771565A2 (de) 1997-05-07
DE69628050D1 (de) 2003-06-12
DE69628050T2 (de) 2004-04-01
DE69625575D1 (de) 2003-02-06
NO964514D0 (no) 1996-10-24
US6551999B1 (en) 2003-04-22
PL316669A1 (en) 1997-04-28
DE69625622T2 (de) 2003-08-14
EP0927716A1 (de) 1999-07-07
ATE239698T1 (de) 2003-05-15
ES2190139T3 (es) 2003-07-16
MX9605156A (es) 1998-05-31
NO964514L (no) 1997-04-28

Similar Documents

Publication Publication Date Title
DE69625622D1 (de) Angiogenese Inhibitoren
FI963597A (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
FI972160A (fi) Matriisimetalloproteaasi-inhibiittorit
NO962381L (no) Spiss-beskytter-innretning
PT858464E (pt) Inibidores de trombina
DE59609887D1 (de) Substituierte cyanophenyluracile
NO980643D0 (no) Propylendopeptidase inhibitorer
DE59610332D1 (de) Substituierte aminouracile
PT863916E (pt) Tripeptidos de polifluoroalquil triptofano inibidores de trombina
BR9608890A (pt) N-metilenotiouréias substituídas
BR9609319A (pt) Carbonilaminofeniluracilas substituídas
DE69523450T2 (de) Inhibitor
BR9603376A (pt) Tetrahidro-5-nitro-pirimidinas substituídas
DE59607732D1 (de) Substituierte benzylidencyanessigester
BR9610514A (pt) Inibidores cicloantihelmínticos
DE59607958D1 (de) Substituierte phenyluracile
FI1943U1 (fi) Bomsystem till skogmaskin
KR970703937A (ko) 금속단백질 분해효소 억제제(Metallproteinase inhibitors)
CY2007006I2 (el) Αναστολεις συνθεσεις απολιποπρωτεϊνης-β
NO950285D0 (no) Teletorgteknikk
BR9503278A (pt) Dispositivos absorventes bucais
FI2196U1 (fi) Snoestyrningsblad till snoeslunga
FI2002U1 (fi) Haollare till spoestaell
FI2187U1 (fi) Hoerndetalj till plaottlaoda

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties